Trials of two microbicides to be launched in Africa

doi:10.1136/bmj.328.7443.786

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Stephen Pincock

London

Large scale, phase III clinical trials of two promising HIV microbicides will begin in Africa in the second half of this year, British researchers told a conference in London this week.

A total of 12 000 women in South Africa, Zambia, Tanzania, Uganda, and Cameroon will take part in the three year studies, investigators from Imperial College London and the Medical Research Council said at the meeting, Microbicides 2004.

About 60 microbicide gels or creams are being developed at the moment, …